Letcure 12: Hemorrhoids, Pinworms and Intestinal Gas Flashcards

1
Q

Rectum

A

Semipermeable membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Dentate Line

A
  • Columnar cells
  • Squamous cells

Where you find Sensory pain fibers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Anal Canal

A

Connects rectum and outside of the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Perianal area

A
  • Portion of skin surrounding the
    anus
  • Protective barrier
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Internal Anal Sphincter is

A

voluntary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

External Anal Sphincter is

A

involuntary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Anal (or perianal) abscess

A

Bacterial infection; pus and bacteria collect and obstruct the anal glands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Anal (or perianal) abscess - Signs/Symptoms

A
- Pain (worsens with sitting and
defecation)
- perirectal swelling
- discharge
- fever
- chills
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Anal fissure

A

Slit-like ulcer in anal canal from a traumatic tear (e.g passage of stool; anal intercourse)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Anal fissure -Signs and Symptoms

A

Severe or burning pain during/after defecation, lasting several minutes to hours; anal spasms; blood may be seen on toilet tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Anal fistula

A

Abnormal internal opening that connects with the external opening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Anal fistula- Signs and Symptoms

A

Chronic, persistent drainage; pain; possible bleeding on defecation; perianal itching; stool seeping through
external opening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Anal neoplasm

A

Anal cancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Anal neoplasm- Signs and Symptoms

A
  • Rare and usually asymptomatic
  • bleeding
  • changes in bowel habits
  • anal discharge
  • anal mass
  • pain
  • pruritus
  • rash
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pathophysiology of Hemorrhoids

A
  • Defecation = downward pressure on blood vessels, smooth muscle, and connective tissue in anal canal
  • Weakening and displacement of tissues
  • Blood vessels become inflamed, bleed, and protrude
  • Ultimately leads to hemorrhoids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Causes/Risk Factors of Hemorrhoids

A
  • Age (45-65 years at greatest risk)
  • Anal intercourse
  • Chronic diarrhea or constipation
  • Lack of physical activity
  • Obesity
  • Poor bowel habits (i.e. prolonged sitting, straining during defecation)
  • Pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Clinical Presentation for Hemorrhoids

A
Burning
Discomfort
Inflammation
Irritation
Pruritus
Swelling
Bleeding
Change in bowel pattern
Pain
Prolapse/Protrusion
Seepage
Thrombosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Exclusions to Self-Care: Hemorrhoids

A
  • Age < 12 years
  • Diagnosed gastrointestinal diseases associated with
    colorectal bleeding
    • Crohn disease, ulcerative colitis
  • Family history of colon cancer
  • Potentially serious anorectal disorder
    • Abscess, fissure, fistula, malignancy/neoplasm
  • Severe associated signs/symptoms:
    • Black, tarry stools, bleeding, pain, prolapse, seepage, thrombosis
    • Burning, discomfort, inflammation, pruritus, swelling
  • Minor symptoms that do not respond to 7 days of self treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Hemorrhoids: Goals of Self-Treatment

A
  1. Maintain soft stools and preventing straining during
    defecation.
  2. Alleviate and maintain remission of anorectal symptoms.
  3. Prevent anorectal complications.
  4. Prevent and manage unwanted effects of medications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Hemorrhoids are:
A. Harmless growths
B. Infected tissue
C. Swollen Veins

A

C. Swollen Veins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

_________ may promote hemorrhoidal bleeding?
A.acetaminophen B.diphenhydramine
C.guaifenesin
D.naproxen

A

D.naproxen

Aspirin and NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Non-Pharmacologic Therapy: Hemorrhoids

A

Diet

  • Increase dietary fiber (25-40 grams per day)
  • Increase fluid intake
  • Proper Bowel Habits
  • Avoid “holding it”
  • Avoid sitting on toilet for long periods
  • Proper anal hygiene
  • Avoidance Measures
  • Avoid lifting heavy objects
  • Discontinue aggravating foods/beverages
  • Alcohol, caffeine, spicy foods
  • NSAIDs and Aspirin may promote bleeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Pharmacologic Therapy

A
Topical Products
§ Analgesics
§ Antipruritics
§ Astringents
§ Corticosteroids
§ Keratolytics
§ Local anesthetics
§ Protectants
§ Vasoconstrictors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Analgesics, Anesthetics, Antipruritics Products and Dosing

A

Camphor
Juniper Tar
Menthol

  • Up to 6times/day
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Analgesics, Anesthetics, Antipruritics Purpose

A

Relief for itching and inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Analgesics, Anesthetics, Antipruritics MOA

A

Provides a cool, warm, or tingling sensation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Analgesics, Anesthetics, Antipruritics Warnings/Precautions

A
  • Do not use internally

- Use sparingly/ not frequently- in small amounts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Astringents Products and Dosing

A

Calamine
Witch Hazel
Zinc Oxide

-Up to 6times/day or after each bowel movement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Astringents Purpose

A
  • Promoted coagulation of protein in skin cells to protect underlying tissue
  • Dries affected area
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Astringents MOA

A
  • Decrease cell volume
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Astringents Warnings/Precautions

A

Zinc oxide: systemic zinc toxicity potential with

overuse (nausea, vomiting, lethargy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Astringents Adverse Effects

A
  • Witch hazel contains alcohol
    • May cause stinging
  • Contact dermatitis (rare)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Corticosteroids Product and Dosing

A

Hydrocortisone 1%

Up to 3-4 times/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Corticosteroids Purpose

A

Relief of itching and irritation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Corticosteroids MOA

A

Vasoconstrictor and antipruritic (anti-itch)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Corticosteroids Warnings/Precautions

A

May mask symptoms of bacterial and fungal infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Corticosteroids Adverse Effects

A

Skin atrophy and reactions (rare)

atrophy- wasting away or diminution (reduction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Corticosteroids PK

A
  • Onset of action: up to 12 hours

- Duration of action: longer lasting than other agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Keratolytics Product and Dosing

A

Alcloxa
Resorcinol

Up to 6 times/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Keratolytics Purpose

A

Debridement of epidermal surface cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Keratolytics MOA

A

Fosters cell turnover and loosens surface cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Keratolytics Warnins/Precautions

A

Do not use internally

  • May expose underlying tissue
  • Systemic absorption
  • Exfoliative dermatitis, methemoglobinemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Keratolytics Notes

A

Balance between benefits and adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Local Anesthetics Product and Dosing

A

Dibucaine-Up to 3/4 times/day

Pramoxine- Up to 5 times/day

Benzocaine, Lidocaine and Tetracaine- Up to 6 times/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Local Anesthetics Purpose

A

Temporary relief of external anal symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Local Anesthetics MOA

A

Inhibit conduction of nerve impulses

47
Q

Local Anesthetics Warnings/Precautions

A
  • May mask pain in more severe disorders
    -Do NOT place on open sores
  • Systemic absorption -> CV and CNS
    Cardiovascular and Central Nervous System
48
Q

Local Anesthetics Adverse Effects

A

Burning and stinging

49
Q

Protectants Products and Dosing

A
Cocoa Butter
Glycerin
Lanolin
Mineral Oil
White petrolatum

Up to 6 times/day or after each bowel movement

50
Q

Protectants Purpose

A

Protective barrier and softening of anal canal

51
Q

Protectants Mechanism

A

Lubricant

52
Q

Protectants Warnings/Precautions

A

Lanolin: obtained from sheep
• High risk of allergies

  • Greasy feel with ointments
53
Q

Protectants Adverse Effects

A

Minimal

54
Q

Vasoconstrictors Products and Dosing

A

Ephedrine
Epinephrine
Phenylephrine

Up to 4 times/day

55
Q

Vasoconstrictors Purpose

A

Relief of itching, discomfort, irritation, swelling

56
Q

Vasoconstrictors Mechanism

A

Stimulation of alpha-adrenergic receptors in vascular beds to
constrict arterioles and reduce swelling

57
Q

Vasoconstrictors Adverse Effects

A
  • Increased cardiac rate/contractility
  • Increased blood pressure (if absorbed systemically)
  • Contact dermatitis
58
Q

Vasoconstrictors Do NOT use for Self-care: Contraindications

A

Antidepressants, cardiac medications, Diabetes Mellitus (DM), enlarged prostate, heart disease, HTN( Hypertension), thyroid disease

59
Q

Topical Considerations for Pharmacologic Therapy

A
§ Applicators
§ Creams
§ Foams
§ Ointments
§ Suppositories- NOT first line – may migrate from affected anal region easily; slower onset of action

Combination products- Often a good choice

60
Q

Patient Education: Non-pharmacologic measures

A
  • Avoid constipating medications
  • Bowel habits
  • Maintain hydration and healthy diet
  • Proper anal hygiene
61
Q

Patient Education: Pharmacologic products

A
  • Select ingredients needed to relieve specific symptoms
  • Reduction or relief of symptoms should occur within a few days
  • Appropriate use of dosage form based on patient’s preference
62
Q

Hemorrhoids: Refer if

A

Presence of serious/severe symptoms and progressive
worsening of symptoms

Symptoms persist beyond 7 days of self treatment

63
Q

Pinworms are called

A

Enterobius vermicularis

64
Q

Enterobius vermicularis

A

Small, thin, white roundworm
- Intestinal helminth/nematode (roundworms) cause enterobiasis (pinworm infection)
- Parasite
- Most common worm infestation in the United States
- Mostly commonly affects children (5-14 years) and
household members
- High prevalence in day care settings and urban areas
- Transferable only among humans

65
Q

Pinworm Lifecycle

A
  1. Ingestion of pinworm eggs
  2. Adult female matures (1-2 months)
  3. Adult female migrate to colon at night
  4. Lays eggs around the anus and female dies
  5. Larvae in eggs develop in 4-6 hours
    * cycle continues*
66
Q

Pinworm Pathophysiology

A
- Eggs can be transmitted via
fomites/contaminated hands
- Eggs are very small
• Can ingest while breathing
•Larvae may return to colon
through anus (retroinfection)
  • Reinfection is common
  • Eggs are viable for 20 days
    outside intestinal tract
67
Q

Clinical Presentation of pinworms

A
  • Often asymptomatic
    -Pruritus ani
    •Typically at night
    • Inflammatory reaction of pinworm on skin

-Major infestations
- Abdominal pain, anorexia, insomnia, intractable itching
- Psychosocial trauma
- Complications
- Bacterial infection secondary to scratching
•Female genital tract
•Perianal and perineal regions
•Urinary tract infections

68
Q

Diagnosis Options

A
  1. Tape test
    - Touch perianal skin with clear tape first thing in morning
    - Perform on 3 consecutive mornings before any washing/hygiene
    - Provider examines tape with microscope
69
Q

Diagnosis Options 2

A
  1. Visual inspection
    - Look for pinworms overnight at least 2-3 hours after infected
    person is asleep
    - Worms are 3-7 mm
70
Q

Diagnosis Options 3

A
  1. Fingernail examination

- Look at fingernails under microscope

71
Q

Exclusions to Self-Care: Pinworms

A
  • Age < 2 years or weight < 25 pounds unless PCP has
    approved OTC treatment
  • Breastfeeding/ Pregnancy
  • Helminthic infections other than pinworms
  • Hypersensitivity to pyrantel pamoate (option that treats this)
  • Liver disease
  • Need for repeat dosing
  • Vague symptoms and negative visual inspection
72
Q

Goals of Self-Treatment: Pinworms

A
  1. Relieve symptoms of pinworm infection.
  2. Eradicate pinworms from patient and household.
  3. Prevent and manage unwanted effects of medications.
  4. Prevent reinfection and transmission.
73
Q

Non-Pharmacologic Therapy: Pinworms

A
Proper hygiene
§ Wash hands with soap and water
§ Keep fingernails short and clean
§ Discourage biting nails and scratching perianal area
§ Daily showers
  • Wash bedlinens, underwear, and towels
    § Use hot water for washing and hot drying cycle
    § Pinworm eggs are killed by temperatures > 131 ℉
    §Change underwear, clothes, and bedlinens daily for several days after treatment
74
Q

Pinworms are killed by temperatures

A

greater than 131 ˚F

75
Q

Pharmacologic Therapy: Pinworms

A

Pyrantel pamoate
§ May not reliably kill pinworms
§ Second dose often used to prevent reinfection
§ Variable efficacy due to effect on eggs and egg viability for up to
20 days

76
Q

Pyrantel Pamoate Brand Name

A

Pin-X,

Reese’s

77
Q

Pyrantel Pamoate MOA

A

Depolarizing neuromuscular agent
This paralyzes adult worms Which loosens worms’ hold on intestinal wall
Then results in worm passed in stool before eggs are laid

78
Q

Pyrantel Pamoate Contraindications

A

Hypersensitivity

79
Q

Pyrantel Pamoate Precautions

A

Hepatic impairment

80
Q

Pyrantel Pamoate Adverse effects

A

Common: abdominal cramps; diarrhea; nausea; vomiting

Less common: dizziness; headache; rash

81
Q

Pyrantel Pamoate Dosing

A

11 mg/kg by mouth as a single dose
§ Maximum single dose = 1 gram
§ Dose can be repeated in 2 weeks if symptoms do not resolve
(consult PCP)

82
Q

Pyrantel Pamoate Patient Education

A

Take with or without food at any time of day
• May mix with juice or milk

  • Treat ALL members of the household to ensure elimination of the
    infection
  • Administered as a SINGLE dose
  • Weight-based dosing is the same for all patients ≥ 2 years
83
Q

Evaluation of Patient Outcomes

A

Refer if Symptoms persist beyond 2 weeks after initial dose of pyrantel pamoate

-PCP may recommend a second dose

84
Q

Intestinal gas pathophysiology

A

Colonic fermentation is the primary process for intestinal gas generation

  • Influenced by type and quantity of food ingested
  • Amount of air entering the upper GIT with swallowing
  • Bacterial overgrowth of small intestine
  • Medical conditions and Medications can cause this
85
Q

Common gas-producing foods

A
  • Beans
    § Carbonated beverages
    § Complex carbohydrates
    § Dairy products
    § Fatty foods
    § Fruits: apricots, bananas, dried fruit, prunes
    § Vegetables: Brussels sprouts, cabbage, cauliflower, onions
86
Q

Things that cause larger amounts of air swallowed

A
§ Chewing gum/hard candies
§ Drinking carbonated beverages
§ Hyperventilating
§ Poor eating habits
§ Poor-fitting dentures
§ Smoking
87
Q

Medical conditions that can cause Intestinal Gas

A
Carbohydrate malabsorption
§ Lactase deficiency
§ Celiac disease
§ Diabetic gastroparesis
§ Irritable bowel syndrome (IBS)
§ Pancreatic insufficiency
88
Q

Medications that can cause Intestinal Gas can/are

A

§ Affect GI motility, intestinal flora, or metabolism of glucose and
other dietary substances
§ Are high in fiber
§ Contain or release gas

89
Q

Clinical Presentation: Intestinal Gas

A
Common symptoms:
§ Abdominal discomfort or cramping
§ Bloating
§ Excessive belching
§ Flatulence 

Associated Symptoms
§ Audible bowel sounds
§ Dyspepsia
§ Nausea

90
Q

Exclusions to Self-Care: Intestinal Gas

A
  • Symptoms that persist for more than several days or occur more often than occasionally (several times a month)
  • Severe debilitating symptoms
  • Sudden change in location of abdominal pain, significant
    increase in frequency/severity of symptoms
  • onset of
    symptoms in individuals > 40 years of age
  • Significant abdominal discomfort or a sudden change in
    bowel function
  • Presence of accompanying symptoms such as severe or
    persistent diarrhea or constipation, GI bleeding, fatigue, unintentional weight loss, or frequent nocturnal symptoms
91
Q

Goals of Self-Treatment: INTESTINAL GAS

A
  1. Reduce frequency, intensity, and duration of intestinal gas
    symptoms.
  2. Reduce the impact of intestinal gas symptoms on the
    patient’s lifestyle.
  3. Prevent and manage unwanted effects of medications.
92
Q

Non-Pharmacologic Therapy:

A
  • Avoid tight-fitting clothing and belts
  • Chew food thoroughly
  • Do not attempt to induce belching or strain to pass gas
  • Do not lie down immediately after eating
  • Eat and drink slowly
  • Reduce consumption of gas-producing foods
  • Wear dentures with proper fit
93
Q

Pharmacologic Therapy:

A

Antiflatulent products

  • Limited supporting evidence
  • Relieve symptoms after intestinal gas has formed
  • Digestive enzymes
  • Symptoms associated with foods containing lactose or oligosaccharides
  • Prevent gas from forming
94
Q

Intestinal Gas Pharmacologic Agents

A

Simethicone
Alpha-Galactosidase
Lactase Replacement Products

95
Q

Simethicone Brand Name

A

Gas-X

Mylicon

96
Q

Simethicone MOA

A

Defoaming agent – reduces surface tension of gas bubbles embedded in GIT

97
Q

Simethicone Dosing

A

Adults: 40-125 mg by mouth after meals and at bedtime as needed
Children ≥ 12 years: 40-125 mg by mouth 4 times daily
Children 2 to < 12 years: 40-50 mg by mouth four times daily
Children < 2 years: 20 mg by mouth four times daily as needed

98
Q

Simethicone Contraindications

A

Hypersensitivity; suspected intestinal perforation and obstruction

99
Q

Simethicone Special Pops

A

Children/ infants and Breastfeeding: considered safe

Pregnancy: fetal risk is minimal

100
Q

Alpha-Galactosidase Brand Name

A

Beano

101
Q

Alpha-Galactosidase MOA

A

Hydrolyzes oligosaccharides before they can be metabolized by colonic bacteria

102
Q

Alpha-Galactosidase Dosing

A

Adults: 300-450 units by mouth per serving of food

103
Q

Alpha-Galactosidase Contraindications

A

Hypersensitivity

104
Q

Alpha-Galactosidase Precautions

A

Diabetes
galactosemia
mold allergies

105
Q

Alpha-Galactosidase- Special Pops

A

Children and infants: avoid use

Pregnancy and Breastfeeding: consult with provider

106
Q

Lactase Replacement Products Brand Name

A

Lactaid, Lactase, etc

107
Q

Lactase Replacement Products MOA

A

Break down lactose, a disaccharide, into the monosaccharides

glucose and galactose, which are absorbed

108
Q

Lactase Replacement Products Dosing

A

Adults ≥ 12 years: 3000-18,000 units by mouth at first bite of food or
drink containing lactose

109
Q

Lactase Replacement Products Special Pops

A

No considerations listed

110
Q

Simethicone

A

Used to treat intestinal gas AFTER it has occurred

111
Q

Alpha-Galactosidase

A

Should be taken with foods to PREVENT intestinal gas from forming

112
Q

Lactase Replacement Products

A

Should be taken with foods to PREVENT intestinal gas from forming
-Take at first bite of dairy or lactose-containing food

113
Q

Non-pharmacologic measures

A
  • Avoid activities known to introduce gas into GIT

- Avoid triggers

114
Q

Evaluation of Patient Outcomes

A
  • Symptoms generally self-limiting within 24 hours

- Follow-up after 1 week of self-care with dietary measures or pharmacologic therapies